BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 12, 2015
View Archived Issues
Tillotts and Numab collaborate on TNF-alpha blockers for inflammatory bowel disease
Read More
BEAM alliance formed to combat antibiotic resistance
Read More
MRC funds U.K. R&D Vaccines Network
Read More
Scripps scientists study mTOR activity in striatum with support from NIH grant
Read More
UNCOVER-1 results reveal efficacy of ixekizumab in plaque psoriasis
Read More
Cellular Biomedicine to acquire CD40LGVAX vaccine
Read More
ASP-8273 well tolerated and active in first-in-human study
Read More
Tumor shrinkage observed in the brain with AZD-3759
Read More
IPO for Cosmo Pharmaceuticals' Cassiopea subsidiary
Read More
Amp biosimilars outlicenses second biosimilar
Read More
Blood glucose lowered with AZP-531 in overweight individuals
Read More
Avilex Pharma receives Wellcome Trust award to develop ischemic stroke candidate
Read More
New molecular imaging probe [99mTc]HYNIC-TCP-1 is selective for colorectal cancer
Read More
NanoCarrier files IND application in Japan for phase I trial of NC-6004 in head and neck cancer
Read More
Phase II trials of F-351 begin in China
Read More
Preclinical data show efficacy of Delenex's DLX-1008 in in vivo models of human glioma
Read More
Takeda patents PKR1 antagonists
Read More
Chinese team presents antidiabetic compounds
Read More
Bayer introduces GLUT-1 inhibitors
Read More
Roche discloses autotaxin inhibitors
Read More
Cancer Research Technology patents RET inhibitors
Read More
TiGenix takes initial steps towards MAA submission for Cx-601
Read More
FDA approves Promacta for children age 6 years and older with chronic ITP
Read More
No safety concerns during 30 days after first patient dosed with Celyad's NKG2D CAR T-cell therapy
Read More
FDA Advisory Committee recommends approval of mepolizumab for severe asthma in adults
Read More